ACAD
#1348
ACADIA Pharmaceuticals Inc. - Common Stock
29.1 1 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.09%
Variación mensual
+12.09%
Variación en los últimos 6 meses
+20.24%
Cambio anual
+12.35%
Cierres anteriores
29.7 3
Open
29.1 1
Mínimo
29.1 1
Máximo
29.1 1
Volumen
118
Financials
- Market Capitalization 5.02 B
- Employee 798
- Founded 1993
- CEO Catherine Owen Adams
- Website www.acadia.com
- Headquarter Delaware, United States
- FIGI BBG000BHG9K0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
11.35
Relación precio/flujo de caja
3.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1279 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.72 USD | -2.78% | -1.52% | +20.15% | +13.18% | 5.58 B USD | ||
| 1289 |  DFTX Definium Therapeutics, Inc. - Common Shares | 40.98 USD | -6.48% | -7.64% | -4.41% | +171.21% | 5.51 B USD | ||
| 1399 |  DYN Dyne Therapeutics, Inc. - Common Stock | 25.07 USD | -3.91% | -4.06% | +0.12% | +7.09% | 4.68 B USD | ||
| 1406 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 42.76 USD | -3.24% | -3.21% | +12.08% | +180.76% | 4.64 B USD |